Abstract
Hair loss is a common complaint that is often stressful for patients and a challenge
for practitioners to treat. Fortunately, innovations in the field have contributed
to growing evidence for several promising topical, oral, and light and energy-based
therapies. We have reviewed the current literature about the efficacy of these treatments,
including topical agents (finasteride, latanoprost, spironolactone, caffeine, and
metformin), oral minoxidil, nutraceuticals, platelet-rich plasma, low-level laser
therapy, fractional lasers, and laser-assisted drug delivery. In addition, several
debates related to these treatments have been discussed, including post-finasteride
syndrome, effects of biotin supplementation on laboratory testing, standardization
of platelet-rich plasma and low-level laser therapy, and combination treatment to
enhance hair transplantation.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinics in DermatologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course.J Dermatol Treat. 1997; 8: 189-192
- Randomized double-blind placebo controlled trial in the treatment of male andro-genetic alopecia with 0.1% finasteride solution.J Dermatol. 2003; 113: 881
- Clinical Evaluation of Topical Formulation of Finasteride in Male Androgenetic Alopecia.Chulalongkorn University, Bangkok, Thailand2006
- Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia.Indian J Dermatol Venereol Leprol. 2009; 75: 47-51
- A Randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.J Eur Acad Dermatol Venereol. 2018; 32: 2257-2263
- Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil solution in female pattern hair loss: a randomized, double-blind, controlled study.Am J Clin Dermatol. 2019; 20: 147-153
- A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers.Int J Clin Pharmacol Ther. 2014; 52: 842-849
- Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: a randomized, placebo-controlled, double-blind, noninferiority study.J Cosmet Dermatol. 2019; 18: 215-220
- Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata.J Dermatol Treat. 2018; 29: 55-64
- Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro.Int J Dermatol. 2007; 46: 27-35
- Differential effects of caffeine on hair shaft elongation, matrix and outer root sheath keratinocyte proliferation, and transforming growth factor-β2/insulin-like growth factor-1-mediated regulation of the hair cycle in male and female human hair follicles in vitro.Br J Dermatol. 2014; 171: 1031-1043
- Clinical efficacy of a topical compounded formulation in male androgenetic alopecia: minoxidil 10%, finasteride 0.1%, biotin 0.2%, and caffeine citrate 0.05% hydroalcoholic solution.Int J Pharm Compd. 2020; 24: 69-76
- Follicular penetration of topically applied caffeine via a shampoo formulation.Skin Pharmacol Physiol. 2007; 20: 195-198
- Efficacy of a cosmetic phyto-caffeine Shampoo in female androgenetic alopecia.G Ital Dermatol Venerol. 2020; 155: 492-499
- Hair regrowth in 2 patients with recalcitrant central centrifugal cicatricial alopecia after use of topical metformin.JAAD Case Rep. 2020; 22: 106-108
- Post-finasteride syndrome: a surmountable challenge for clinicians.Fertil Steril. 2020; 113: 21-50
- Effect of 5α-reductase inhibitors on sexual function: a meta-analysis and systematic review of randomized controlled trials.J Sex Med. 2016; 13: 1297-1310
- PLESS Study Group. Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia.Urology. 2003; 61: 579-584
- Post-finasteride syndrome.BMJ. 2019; 366: I5047
- Long-term consequences of finasteride vs placebo in the Prostate Cancer Prevention Trial.J Natl Cancer Inst. 2016; 108: djw168
- Investigation of the plausibility of 5-alpha-reductase inhibitor syndrome.Skin Appendage Disord. 2017; 2: 120-129
- Side effects related to 5 α-reductase inhibitor treatment of hair loss in women: a review.J Drugs Dermatol. 2016; 15: 414-419
- The efficacy and use of finasteride in women: a systematic review.Int J Dermatol. 2019; 58: 759-776
- Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: a comprehensive review.Dermatol Online J. 2017; 23: 13030
- Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia.J Am Acad Dermatol. 2019; 81: 648-649
- Efficacy and safety of oral minoxidil 5 mg daily during 24-week treatment in male androgenetic alopecia.J Am Acad Dermatol. 2015; 72: AB113
- Case series of oral minoxidil for androgenetic and traction alopecia: tolerability & the Five C's of oral therapy.Dermatol Ther. 2018; 31: e12707
- Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: a randomized clinical trial.J Am Acad Dermatol. 2020; 82: 252-253
- Oral minoxidil: a possible new therapy for androgenetic alopecia.J Cutan Med Surg. 2020; 24: 88-89
- Use of dietary supplements by cardiologists, dermatologists and orthopedists: report of a survey.Nutr J. 2011; 10: 20
- Assessment of biotin supplementation among patients in an outpatient dermatology clinic.J Am Acad Dermatol. 2019; 81: 610-621
- Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults.JAMA. 2017; 318: 1150-1160
- Rethinking biotin therapy for hair, nail, and skin disorders.J Am Acad Dermatol. 2018; 78: 1236-1238
- A novel multi-targeting approach to treating hair loss, using standardized nutraceuticals.J Drugs Dermatol. 2017; 16: s141-s148
- Stress and the hair growth cycle: cortisol-induced hair growth disruption.J Drugs Dermatol. 2016; 15: 1001-1004
- A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study.J Am Nutraceut Assoc. 2008; 11: 50-66
- Dietary Supplements: A Framework for Evaluating Safety.National Academies Press (US), Washington, DC2005 (. Appendix K, Prototype Focused Monograph: Review of Antiandrogenic Risks of Saw Palmetto Ingestion by Women. Available at: https://www.ncbi.nlm.nih.gov/books/NBK216069/)
- A six-month, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of a nutraceutical supplement for promoting hair growth in women with self-perceived thinning hair.J Drugs Dermatol. 2018; 17: 558-565
- A 3-month, randomized, double-blind, placebo-controlled study evaluating the ability of an extra-strength marine protein supplement to promote hair growth and decrease shedding in women with self-perceived thinning hair.Dermatol Res Pract. 2015; 2015841570
- A 6-month, randomized, double-blind, placebo-controlled study evaluating the ability of a marine complex supplement to promote hair growth in men with thinning hair.J Cosmet Dermatol. 2016; 15: 358-366
- The physician's guide to platelet-rich plasma in dermatologic surgery part I: definitions, mechanisms of action, and technical specifications.Dermatol Surg. 2020; 46: 348-357
- Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth.Dermatol Surg. 2012; 38: 1040-1046
- Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).Trends Biotechnol. 2009; 27: 158-167
- Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives.Muscles Ligaments Tendons J. 2014; 4: 3-9
- DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices.BMJ Open Sport Exerc Med. 2016; 2e000060
- Platelet-rich plasma and its utilities in Alopecia: a systematic review.Dermatol Surg. 2019; 46: 93-102
- A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata.Br J Dermatol. 2013; 169: 690-694
- Intralesional platelet rich plasma vs intralesional triamcinolone in the treatment of alopecia areata: a comparative study.Int J Med Res Heal Sci. 2015; 4: 118
- Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: a trichoscopic evaluation.Dermatol Ther. 2017; 30: e12437
- The effect of platelet- rich plasma in hair regrowth: a randomized placebo-controlled trial.Stem Cell Transl Med. 2015; 4: 1317-1323
- The effect of autologous activated platelet-rich plasma injection on female pattern hair loss: a randomized placebo-controlled study.J Cosmet Dermatol. 2018; 17: 47-53
- Evaluation of not-activated and activated PRP in hair loss treatment: role of growth factor and cytokine concentrations obtained by different collection systems.Int J Mol Sci. 2017; 18: 408
- A spilt head study of efficacy of placebo versus platelet-rich plasma injections in the treatment of androgenic alopecia.J Cutan Aesthet Surg. 2017; 10: 86-89
- Therapeutic efficacy of autologous platelet-rich plasma and polydeoxyribonucleotide on female pattern hair loss.Wound Repair Regen. 2015; 23: 30-36
- Double-blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia.Dermatol Surg. 2016; 42: 1243-1247
- Platelet-rich plasma by single spin process in male pattern androgenetic alopecia: is it an effective treatment?.Indian Dermatol Online J. 2017; 8: 460-464
- Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: a pilot randomized controlled trial.J Cosmet Laser Ther. 2016; 18: 452-455
- Original article: platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and post-treatment evaluation.J Cosmet Dermatol. 2018; 17: 313-318
- Platelet-rich plasma in combination with 5% minoxidil topical solution and 1 mg oral finasteride for the treatment of androgenetic alopecia.Dermatol Surg. 2018; 44: 126-130
- The effect of plasma rich in growth factors on pattern hair loss.Dermatol Surg. 2017; 43: 658-670
- A critical assessment of the evidence for low-level laser therapy in the treatment of hair loss.Dermatol Surg. 2017; 43: 188-197
- Laser-assisted drug delivery for the treatment of androgenetic alopecia: ablative laser fractional photothermolysis to enhance cutaneous topical delivery of platelet-rich plasma–with or without concurrent bimatoprost and/or minoxidil.Dermatol Online J. 2019; 25: 13030
- Utilizing electromagnetic radiation for hair growth: a critical review of phototrichogenesis.Dermatol Clin. 2013; 31: 193-200
- Interplay between up-regulation of cytochrome-c-oxidase and hemoglobin oxygenation induced by near-infrared laser.Sci Rep. 2016; 6: 30540
- Exact action spectra for cellular responses relevant to phototherapy.Photomed Laser Surg. 2005; 23: 355-361
- Evaluation of wavelength-dependent hair growth effects on low-level laser therapy: an experimental animal study.Lasers Med Sci. 2015; 30: 1703-1709
- Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a system review and meta-analysis of randomized controlled trials.Lasers Med Sci. 2019; 34: 1063-1069
- The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia.Indian J Dermatol Venereol Leprol. 2018; 84: 547-553
- Efficacy of fractional lasers in treating alopecia: a literature review.Lasers Med Sci. 2017; 32: 1919-1925
- The effect of a 1550 nm fractional erbium-glass laser in female pattern hair loss.J Eur Acad Dermatol Venereol. 2011; 25: 1450-1454
- Fractional photothermolysis laser treatment of male pattern hair loss.Dermatol Surg. 2011; 37: 41-51
- Alopecia areata: good response to treatment with fractional laser in 5 cases.J Cosmo Trichol. 2016; 2: 108
- The effect of neodymium: yttrium aluminum garnet and fractional carbon dioxide lasers on alopecia areata: a prospective controlled clinical trial.Dermatol Surg. 2016; 42: 500-506
- Clinical effects of non-ablative and ablative fractional lasers on various hair disorders: a case series of 17 patients.J Cosmet Laser Ther. 2013; 15: 74-79
- Erbium-yttrium- aluminum-garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs.J Pharm Sci. 2014; 103: 3542-3552
- The effect of the fractional carbon dioxide laser on improving minoxidil delivery for the treatment of androgenetic alopecia.J Lasers Med Sci. 2020; 11: 29-36
- Enhancing hair growth in male androgenetic alopecia by a combination of fractional CO2 laser therapy and hair growth factors.Lasers Med Sci. 2017; 32: 1711-1718
- A pilot split-scalp study of combined fractional radiofrequency microneedling and 5% topical minoxidil in treating male pattern hair loss.Clin Exp Dermatol. 2018; 43: 775-781
- Hair transplantation controversies.Dermatol Surg. 2017; 43: S158-S162
- Outcome of intra-operative injected platelet-rich plasma therapy during follicular unit extraction hair transplant: a prospective randomised study in forty patients.J Cutan Aesthet Surg. 2016; 9: 157-164
Article info
Publication history
Published online: August 08, 2021
Identification
Copyright
© 2021 Published by Elsevier Inc.
